AzTrials
AzTrials

EdentulousNCT02546713

Abutment Macro Design and Peri-implant Tissues

A study testing Abutment with concave subcritical contour and Abutment with convex subcritical contour in people with Edentulous, run by Nova Southeastern University at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The aim of this study is to evaluate the effect of abutment macro-design on soft and hard tissue responses. This trial is designed as a randomized controlled clinical study in which two groups of fourteen partially edentulous patients will have as part of their treatment one implant placed in the maxillary premolar… Read more about this study

Who is it for?
Ages 21 years and older
Conditions the study is for
Edentulous
What is being tested?
Abutment with concave subcritical contour and Abutment with convex subcritical contour
Could I receive a placebo?
No, everyone receives an active treatment
How many people
28 participants
Where
1 siteUnited States
Study dates
Dec 2015to 30 Nov 2021
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 21 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

General Inclusion criteria:

  • - Age more than 21 years
  • Absence of relevant medical conditions
  • Availability for 12 month follow-up

Specific Inclusion criteria:

  • One missing tooth in the maxillary premolar region
  • Presence of two adjacent teeth at the implant site
  • Absence of periodontal disease
  • Healed osseous architecture enough to receive an implant with a diameter of at least 3.5 mm and a sufficient amount of bone for placing implants with a length of at least 9 mm

General Exclusion Criteria:

  • - Pregnancy at the screening visit.
  • Smoking more than 10 cig/day

Specific Exclusion criteria:

  • Adjacent implants
  • Presence of periapical radiolucency at the adjacent teeth
  • Missing adjacent teeth

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Nova Southeastern University

    Fort Lauderdale, Florida, 33328

Other trials in United States

About this study

Official title: The Influence of Abutment Macro-design on Peri-implant Tissue Dimensions for Guided Placed and Restored Implants

The aim of this study is to evaluate the effect of abutment macro-design on soft and hard tissue responses. This trial is designed as a randomized controlled clinical study in which two groups of fourteen partially edentulous patients will have as part of their treatment one implant placed in the maxillary premolar region.

Read the detailed description

Implant placement and abutment design will be planned with a computer software for guided implant treatment (SIMPLANT). The surgical implant placement will be performed under manufacturer's protocol by placing the implant platform 1mm below the buccal aspect of the osteotomy (Koutouzis et al 2013). Virtually designed, permanent CAD-CAM fabricated abutments (ATLANTIS, DENTSPLY) with different configuration of the subcritical contour (emergence shape) will be connected to the implants and temporary crowns will be delivered.

Implants of the Group 1 will have permanent abutments with a concave configuration of the subcritical contour (emergence shape).

Implants of the Group 2 will have permanent abutments with a convex configuration of the subcritical contour (emergence shape).

The patients will be restored with single crowns 3 months following implant installation.

A randomization protocol will be produced from a computer-generated list for the distribution of subjects in the two treatment groups.

Conditions
Edentulous
Being tested
Abutment with concave subcritical contour, Abutment with convex subcritical contour
Keywords
dental implants
Medical subject headings
Mouth, Edentulous

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Abutment with concave subcritical contourOther

    Implants will be restored with abutments with concave configuration of the subcritical contour

  • Abutment with convex subcritical contourOther

    Implants will be restored with abutments with convex configuration of the subcritical contour

Study groups in NCT02546713
Study groupRoleWhat they receive
Group 1OtherAbutments with a concave configuration of the subcritical contour (emergence shape).
Receives: Other: Abutment with concave subcritical contour
Group 2OtherAbutments with convex configuration of the subcritical contour (emergence shape)
Receives: Other: Abutment with convex subcritical contour

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Peri-implant mucosa margin position change

    The primary outcome variable will be change on peri-implant mucosa margin position.

    Measured: Day 7-10 to the Day 360

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted11 Sep 2015 (estimated)
  2. Study startDec 2015
  3. Primary completionDec 2020
  4. Study completion30 Nov 2021

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
28 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02546713
Sponsor's protocol ID
I-AA-14-075
Status last verified
Apr 2022
First submitted
9 Sep 2015
Last updated
13 Apr 2022
Results posted
No
Data monitoring committee
No

Publications

  • Koutouzis T, Neiva R, Nair M, Nonhoff J, Lundgren T. Cone beam computed tomographic evaluation of implants with platform-switched Morse taper connection with the implant-abutment interface at different levels in relation to the alveolar crest. Int J Oral Maxillofac Implants. 2014 Sep-Oct;29(5):1157-63. doi: 10.11607/jomi.3411.

    PubMed 25216143
  • Koutouzis T, Koutouzis G, Tomasi C, Lundgren T. Immediate loading of implants placed with the osteotome technique: one-year prospective case series. J Periodontol. 2011 Nov;82(11):1556-62. doi: 10.1902/jop.2011.100751. Epub 2011 May 4.

    PubMed 21542730

Questions about this trial

What is this clinical trial studying?

A study testing Abutment with concave subcritical contour and Abutment with convex subcritical contour in people with Edentulous, run by Nova Southeastern University at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 13 Apr 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Peri-implant mucosa margin position change (time frame: Day 7-10 to the Day 360). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02546713, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Apr 2022; AzTrials last refreshed its copy on 31 Oct 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in